CORRELATION DEGREES OF TUMOR INFILTRATING LYMPHOCYTES (TILs) WITH GLEASON SCORE IN PROSTATE ADENOCARCINOMA

Mitchell Theny, Irene L Parengkuan, Paul L Tahalele

Abstract


Introduction: One of the abnormalities in the prostate gland is prostate adenocarcinoma. Prostate adenocarcinoma expresses tumor antigen in the form of Prostate Specific Antigen (PSA) which will then be recognized by the immune system. The immune system then responds by infiltrating the tumor tissue. Tumor Infiltrating Lymphocytes (TILs) are defined as the infiltration of lymphocytes into the tumor microenvironment. T lymphocytes have a role in recognizing and killing tumor cells. The Gleason grading system together with serum PSA assessment and clinical staging are key in determining appropriate therapy and prognosis in prostate adenocarcinoma. The Gleason grading system is used to assess the degrees of glandular differentiation in prostate adenocarcinoma. An increase in the gleason score indicates poor gland differentiation.

Purpose: To assess the correlation between the degrees of Tumor Infiltrating Lymphocytes (TILs) with gleason score in prostate adenocarcinoma.

Method: This retrospective study used a correlation analytic method with a cross sectional study design that measured the degrees of Tumor Infiltrating Lymphocytes (TILs) in each gleason score of prostateadenocarcinoma that was observed once at a time. The research samples obtained from the patient's medical records included the gleason score and histopathological slides of the Transurethral Resection of Prostate (TURP) with hematoxylin eosin (HE) staining which were diagnosed as prostate adenocarcinoma according to the inclusion criteria using the non-probability total sampling method at Dr.RamelanNavy’s Central Hospital and analyzed using SPSS version 25 application.

Result: Spearman correlation test to assess the correlation between the degree of stromal TILs with gleason score obtained p-value = 0.345 (p >0.05) which indicates there is nocorrelation.

Conclusion: There is nocorrelation between high grade stromal TILs and high Gleason Score in prostate adenocarcinoma

Save to Mendeley


Keywords


Prostate Adenocarcinoma; Tumor Infiltrating Lymphocytes; Gleason Score

Full Text:

PDF

References


Blankenstein, T. et al. (2012) ‘The determinants of tumour immunogenicity’, Nature Reviews Cancer. Nat Rev Cancer, pp. 307–313. doi: 10.1038/nrc3246.

Chen, N. and Zhou, Q. (2016) ‘The evolving Gleason grading system’, Chinese Journal of Cancer Research, 28(1), p. 58. doi: 10.3978/J.ISSN.1000-9604.2016.02.04.

Diana, D. and Kusmardi (2020) ‘Tumor-infiltrating lymphocytes dan Peranannya pada Karsinoma Payudara’, Maj Patol Indones, 29(1), pp. 30–40.

Drake, R. L., Vogl, A. W. and Mitchell, A. W. M. (2015) Gray Dasar-Dasar Anatomi. Elsevier.

Duarsa, G. W. K. (2020) Luts, Prostatitis, BPH Dan Kanker Prostat. Airlangga University Press.

Epstein, J. I. et al. (2005) ‘The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma’, American Journal of Surgical

Pathology, 29(9), pp. 1228–1242. doi: 10.1097/01.PAS.0000173646.99337.B1.

Kumar, Vinay; Abbas, Abul; Aster, J. (2013) Buku Ajar Patologi Robbins. 9th edn. Elsevier.

Mao, W. et al. (2019) ‘Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition’, Journal for ImmunoTherapy of Cancer, 7(1), pp. 1–14. doi: 10.1186/s40425-019-0758-y.

Purnomo, B. B. (2016) Dasar-dasar Urologi. 3rd edn. CV Sagung Seto.

Rawla, P. (2019) ‘Epidemiology of Prostate Cancer’, World Journal of Oncology, 10(2), p. 63. doi: 10.14740/WJON1191.

Sharma, M. et al. (2019) ‘Immunohistochemistry of immune checkpoint markers PD-1 and PD-L1 in prostate cancer’, Medicine, 98(38). doi: 10.1097/MD.0000000000017257.

Siregar, M. T., Delyuzar and Laksmi, L. I. (2019) ‘Correlation of Stromal Tumor-Infiltrating Lymphocytes (TILs) Degrees with Total Prostate Specific Antigen (PSA) in Benign Prostate Hyperplasia and Prostate Adenocarcinoma’, International Journal of Scientific and Research Publications (IJSRP), 9(12), p. p9658. doi: 10.29322/ijsrp.9.12.2019.p9658.

Venkatachalam, S. et al. (2021) ‘Immune Checkpoint Inhibitors in Prostate Cancer’, Cancers, 13(9). doi: 10.3390/CANCERS13092187.

World Health Organization (2020) Global Cancer Profile 2020. Available at: https://www.who.int/cancer/country-profiles/Global_Cancer_Profile_2020.pdf?ua=1 (Accessed: 16 April 2021).

World Heath Organization (2020) Indonesia Source: Globocan 2020. Available at: https://gco.iarc.fr/today/ (Accessed: 16 April 2021). Yang, Y. et al. (2021) ‘High intratumoral CD8+ T-cell infiltration is associated with improved survival in prostate cancer patients undergoing radical prostatectomy’, Prostate, 81(1), pp. 20–28. doi: 10.1002/pros.24068.




DOI: https://doi.org/10.33508/jwmj.v4i4.4338

Refbacks

  • There are currently no refbacks.